<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV differs from MERS-CoV because it uses angiotensin-converting enzyme 2 (ACE2) as a receptor for binding to human cells [
 <xref rid="B4-ijerph-17-01633" ref-type="bibr">4</xref>]. In contrast, MERS-CoV uses dipeptidyl peptidase 4 (DPP4) as a receptor for infecting human cells [
 <xref rid="B5-ijerph-17-01633" ref-type="bibr">5</xref>]. Phylogenetically, SARS-CoV and MERS-CoV are distinct and both are distant from other CoVs, including HCoVs.
</p>
